levoamphetamine < levodopa < levodopa adjunctive

Facettes :

List of bibliographic references indexed by levodopa

Number of relevant bibliographic references: 102.
[20-40] [0 - 20][0 - 50][40-60]

Ident.	Authors (with country if any)	Title
000A46 (2009)	Sophie Molloy [Royaume-Uni] ; Thais Minett [Brésil] ; John T. O'Brien [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] ; David J. Burn [Royaume-Uni]	Levodopa use and sleep in patients with dementia with Lewy bodies
000A47 (2009)	Robert A. Hauser [États-Unis] ; Peggy Auinger [États-Unis] ; David Oakes [États-Unis]	Levodopa response in early Parkinson's disease
000A48 (2009)	A. H. V. Schapira [Royaume-Uni] ; M. Emre [Turquie] ; P. Jenner [Royaume-Uni] ; Werner Poewe [Autriche]	Levodopa in the treatment of Parkinson’s disease
000A57 (2009)	Michael Niehues [Allemagne] ; Hensel [Allemagne]	In‐vitro interaction of l‐dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability?
000A67 (2009)	Thomas Müller [Allemagne] ; Wilfried Kuhn [Allemagne]	Homocysteine levels after acute levodopa intake in patients with Parkinson's disease
000B01 (2009)	C. Marin [Espagne] ; E. Aguilar [Espagne] ; G. Mengod [Espagne] ; R. Cortés [Espagne] ; J. A. Obeso [Espagne]	Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats
000B04 (2009)	H. Nissinen [Finlande] ; M. Kuoppam Ki [Finlande] ; M. Leinonen [Suède] ; A. H. Schapira [Royaume-Uni]	Early versus delayed initiation of entacapone in levodopa‐treated patients with Parkinson’s disease: a long‐term, retrospective analysis
000B07 (2009)	Robert A. Hauser [États-Unis] ; Michel Panisset [Canada] ; Giovanni Abbruzzese [Italie] ; Linda Mancione [États-Unis] ; Nalina Dronamraju [États-Unis] ; Algirdas Kakarieka [Suisse]	Double‐blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease
000B08 (2009)	C. G. Bachmann ; A. Zapf [Allemagne] ; E. Brunner [Allemagne] ; C. Trenkwalder	Dopaminergic treatment is associated with decreased body weight in patients with Parkinson’s disease and dyskinesias
000B30 (2009)	D. Nyholm [Suède] ; R. Constantinescu [Suède] ; B. Holmberg [Suède] ; N. Dizdar [Suède] ; H. Askmark [Suède]	Comparison of apomorphine and levodopa infusions in four patients with Parkinson’s disease with symptom fluctuations
000B80 (2009)	Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Shirley W. Eberly [États-Unis] ; David Oakes [États-Unis] ; Stanley Fahn [États-Unis] ; Steven R. Schwid [États-Unis] ; Christopher Hyson [Canada] ; Ira Shoulson [États-Unis]	A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts
000C36 (2008)	Fabrizio Stocchi [Italie] ; Michele Tagliati [États-Unis] ; C. Warren Olanow [États-Unis]	Treatment of levodopa‐induced motor complications
000C45 (2008)	Stanley Fahn [États-Unis]	The history of dopamine and levodopa in the treatment of Parkinson's disease
000C50 (2008)	Anthony H. V. Schapira [Royaume-Uni]	The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease
000C72 (2008)	G. Linazasoro [Espagne] ; J. Kulisevsky [Espagne] ; B. Hernández [Espagne]	Should levodopa dose be reduced when switched to stalevo?
000D09 (2008)	John G. Nutt [États-Unis]	Pharmacokinetics and pharmacodynamics of levodopa
000D33 (2008)	Cory Toth [Canada] ; Martin Sutton Brown [Canada] ; Sarah Furtado [Canada] ; Oksana Suchowersky [Canada] ; Douglas Zochodne [Canada]	Neuropathy as a potential complication of levodopa use in Parkinson's disease
000D54 (2008)	Nir Giladi [Israël]	Medical treatment of freezing of gait
000D61 (2008)	C. Warren Olanow [États-Unis]	Levodopa/dopamine replacement strategies in Parkinson's disease—Future directions
000D62 (2008)	P. Damier [France] ; F. Viallet [France] ; M. Ziegler [France] ; I. Bourdeix [France] ; K. Rerat [France]	Levodopa/DDCI and entacapone is the preferred treatment for Parkinson’s disease patients with motor fluctuations in routine practice: a retrospective, observational analysis of a large French cohort
000D63 (2008)	Kapil Sethi [États-Unis]	Levodopa unresponsive symptoms in Parkinson disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "levodopa" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "levodopa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    levodopa
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024